Bangladesh vs Fiji: Previously treated cases tested for RR-/MDR-TB
Bangladesh
100.0%
in 2024
Fiji
100.0%
in 2024
Bangladesh rank
1st
Fiji rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Bangladesh
- Fiji
How they compare
Bangladesh currently reports 100.0% against 100.0% in Fiji, a difference of 0.0%.
The two have swapped places 6 times across 15 shared years of data; in 2010 it was Fiji ahead.
Bangladesh ranks 1st and Fiji ranks 1st of 180 countries.
Bangladesh has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bangladesh | Fiji | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 51.4% | 48.1% | 3.3% | Bangladesh |
| 2020s | 96.0% | 81.8% | 14.2% | Bangladesh |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Bangladesh or Fiji?
- Bangladesh, at 100.0% against 100.0% in Fiji as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Bangladesh and Fiji?
- 0.0%, with Bangladesh ahead.
- How many years of comparable data are there for Bangladesh and Fiji?
- 15 years are reported by both, from 2010 to 2024.
- How do Bangladesh and Fiji rank globally for previously treated cases tested for rr-/mdr-tb?
- Bangladesh ranks 1st and Fiji ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.